Enveric Biosciences Inc
(ENVB)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 9,632 | 16,448 | 27,415 | 64,623 | 5,617 |
| Operating Income | -9,632 | -16,448 | -27,415 | -64,623 | -5,617 |
| Interest Expense | 0 | 0 | 0 | 10 | 445 |
| Other Income | 66 | -814 | 7,458 | 8,202 | -802 |
| Pre-tax Income | -9,566 | -17,263 | -19,957 | -56,432 | -6,865 |
| Income Tax | 9 | 29 | -1,486 | -7,455 | N/A |
| Net Income Continuous | -9,575 | -17,292 | -18,471 | -48,977 | -6,865 |
| Net Income | $-9,575 | $-17,292 | $-18,471 | $-48,977 | $-6,865 |
| EPS Basic Total Ops | -228.57 | -1,456.06 | -2,339.77 | -18,662.34 | -10,708.93 |
| EPS Basic Continuous Ops | -228.52 | -1,441.55 | -2,299.11 | -18,675.77 | -10,736.17 |
| EPS Diluted Total Ops | -228.57 | -1,456.06 | -2,339.77 | -18,662.34 | -10,708.93 |
| EPS Diluted Continuous Ops | -228.52 | -1,441.55 | -2,299.11 | -18,675.77 | -10,736.17 |
| EPS Diluted Before Non-Recurring Items | -228.57 | -1,441.66 | -1,594.64 | -3,869.61 | -10,708.93 |
| EBITDA(a) | $-9,295 | $-16,040 | $-19,526 | $-25,263 | $-5,208 |